Bradykinin B2 Receptor Antagonist

This page covers all Bradykinin B2 Receptor Antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting B2 bradykinin receptor, Bradykinin B2 receptor.

Targets

B2 bradykinin receptor · Bradykinin B2 receptor

Marketed (1)

• Firazyr · Takeda · Neuroscience
  Firazyr works by blocking the action of bradykinin, a protein that causes blood vessels to swell and leads to symptoms of HAE.

Phase 2 pipeline (1)

• HOE140 Icatibant · Sanofi · Immunology / Rare Disease
  Icatibant is a selective bradykinin B2 receptor antagonist that blocks the inflammatory effects of bradykinin, a key mediator of angioedema.

Patent intelligence

• bradykinin b2 receptor antagonist patent landscape — aggregated cliff calendar, attackable patents, originator estates